Sotera Health (NASDAQ:SHC) Rating Increased to Strong-Buy at Wall Street Zen

Sotera Health (NASDAQ:SHC) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

A number of other analysts also recently issued reports on the company. Piper Sandler cut their price objective on Sotera Health from $15.00 to $13.00 and set a “neutral” rating for the company in a research report on Wednesday, April 23rd. Barclays reissued an “overweight” rating on shares of Sotera Health in a research report on Friday, August 8th. Finally, The Goldman Sachs Group raised Sotera Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Sotera Health currently has a consensus rating of “Buy” and a consensus target price of $16.00.

Sotera Health Trading Down 0.1%

Shares of SHC stock opened at $15.74 on Friday. The stock’s fifty day moving average is $11.93 and its two-hundred day moving average is $12.09. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47. The firm has a market capitalization of $4.47 billion, a P/E ratio of 196.77 and a beta of 1.81. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $17.08.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.03. The company had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.19 EPS. Research analysts expect that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Sotera Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in shares of Sotera Health by 3.1% during the fourth quarter. JPMorgan Chase & Co. now owns 255,341 shares of the company’s stock worth $3,493,000 after purchasing an additional 7,594 shares during the last quarter. Bank of Montreal Can raised its stake in shares of Sotera Health by 10.6% during the fourth quarter. Bank of Montreal Can now owns 18,184 shares of the company’s stock worth $249,000 after purchasing an additional 1,740 shares during the last quarter. Sterling Capital Management LLC raised its stake in shares of Sotera Health by 58.5% during the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company’s stock worth $124,000 after purchasing an additional 3,331 shares during the last quarter. Canada Pension Plan Investment Board raised its stake in shares of Sotera Health by 53.0% during the fourth quarter. Canada Pension Plan Investment Board now owns 15,300 shares of the company’s stock worth $209,000 after purchasing an additional 5,300 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Sotera Health by 27.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company’s stock worth $43,004,000 after purchasing an additional 673,979 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.